HIPRA manufactures vaccines and diagnostic products for animal and human health, operating a vertically integrated biotech supply chain across research, manufacturing, and distribution in 100+ countries. The hiring mix—research-heavy (9 roles), paired with manufacturing, ops, and quality teams—reflects execution of a capital-intensive R&D pipeline alongside compliance and process optimization. Active projects center on Industry 4.0, predictive maintenance, and accelerated cell line generation, while pain points cluster around GMP compliance, deviation reduction, and data integrity—typical friction points for scaled biotech manufacturing under regulatory pressure.
HIPRA is a privately held biotechnology company headquartered in Girona, Spain, with 1,001–5,000 employees. The company develops and manufactures vaccines and diagnostic services, supported by over 50 years of R&D experience. Operations span a vertically integrated value chain—research, production, and commercialization—with commercial subsidiaries and distribution networks reaching customers across 5 continents. The product portfolio covers animal health, human health, and One Health applications, including diagnostic reagents and medical devices. Current hiring is concentrated in Spain across research, manufacturing, operations, quality, and engineering roles.
HIPRA operates a vertically integrated biotech manufacturing operation with emphasis on GMP compliance, process validation, and deviation reduction. Active projects include Industry 4.0 implementation, predictive maintenance, and computerized system validation to optimize manufacturing controls and data integrity.
HIPRA distributes products to customers in more than 100 countries across all 5 continents through commercial subsidiaries and a global distribution network, with headquarters in Girona, Spain.
Other companies in the same industry, closest in size